Antihypertensive Pharmacogenetic Effect of Fibrinogen-beta Variant -455 G>A on Cardiovascular Disease, End-Stage Renal Disease and Mortality: The GenHAT Study

OBJECTIVE: The FGB gene codes for fibrinogen-beta, a polypeptide of the coagulation factor fibrinogen, which is positively associated with cardiovascular diseases. Studies show ACE inhibitors lower plasma fibrinogen concentrations, whereas diuretics and calcium channel blockers do not. Since carrier...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Lynch, Amy I., Boerwinkle, Eric, Davis, Barry R., Ford, Charles E., Eckfeldt, John H., Leiendecker-Foster, Catherine, Arnett, Donna K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2009
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2764310/
https://ncbi.nlm.nih.gov/pubmed/19352213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0b013e32832a8e81
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi